We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ENGN icon
76
enGene Therapeutics
ENGN
$105M
$105M $1.56 1.27%
ANIX icon
77
Anixa Biosciences
ANIX
$104M
$104M $2.99 7.55%
TVGN icon
78
Tevogen Inc
TVGN
$103M
$103M $6.53 4.11%
OKUR icon
79
OnKure Therapeutics
OKUR
$102M
$102M $2.52 2.33%
IMUX icon
80
Immunic
IMUX
$101M
$101M $7.41 2.63%
VTVT icon
81
vTv Therapeutics
VTVT
$101M
$101M $25.55 5.93%
VANI icon
82
Vivani Medical
VANI
$100M
$100M $1.11 1.83%
LENZ icon
83
LENZ Therapeutics
LENZ
$99.3M
$99.3M $3.16 2.77%
CLLS icon
84
Cellectis
CLLS
$98.7M
$98.7M $0.9800 0.51%
CNXU icon
85
Conexeu Sciences Inc
CNXU
$95.6M
$95.6M $3.10 6.06%
NTHI icon
86
NeOnc Technologies
NTHI
$94.2M
$94.2M $3.27 10.8%
ICCC icon
87
ImmuCell
ICCC
$93.1M
$93.1M $10.25 1.82%
INO icon
88
Inovio Pharmaceuticals
INO
$92.8M
$92.8M $0.8971 6.94%
COYA icon
89
Coya Therapeutics
COYA
$92.4M
$92.4M $3.94 4.83%
PLYX icon
90
Polaryx Therapeutics Inc
PLYX
$92.2M
$92.2M $1.85 4.64%
GNLX icon
91
Genelux
GNLX
$90.5M
$90.5M $2 1.01%
TNXP icon
92
Tonix Pharmaceuticals
TNXP
$88.7M
$88.7M $5.17 0.78%
RLYB icon
93
Rallybio
RLYB
$88.4M
$88.4M $16.64 1.46%
TNYA icon
94
Tenaya Therapeutics
TNYA
$87.2M
$87.2M $0.3890 0.26%
ATRA icon
95
Atara Biotherapeutics
ATRA
$86.2M
$86.2M $8.59 8.91%
MIST icon
96
Milestone Pharmaceuticals
MIST
$80.7M
$80.7M $0.6482 7.76%
PDSB icon
97
PDS Biotechnology
PDSB
$80.4M
$80.4M $1.11 4.31%
CRBP icon
98
Corbus Pharmaceuticals
CRBP
$78.3M
$78.3M $4.05 1.94%
EQ icon
99
Equillium
EQ
$78M
$78M $1.23 3.15%
PMN icon
100
ProMIS Neurosciences
PMN
$74.8M
$74.8M $8.34 7.13%

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 296 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $19.3B.

The largest by market cap are Clinuvel Pharmaceuticals (CUVL) at $249M, Cabaletta Bio (CABA) at $249M and Bicycle Therapeutics (BCYC) at $248M.

Among institutional investors, Eledon Pharmaceuticals (ELDN) drew the most net new fund positions in Q2 2026: 51 funds opened new positions, taking total fund holders up 40 (33%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.